Rottapharm Madaus, 6.125% 15nov2019, EUR (XS0808637309)
International bonds
International bonds
explore the most comprehensive database
900 000
bonds globally
Over 400
pricing sources
80 000
stocks
116 000
ETF & Funds
track your portfolio in the most efficient way
full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.
Register
Rottapharm|Madaus engages in research, development, manufacturing, global marketing and distribution of branded clinically proven consumer healthcare products (“Cx-Products”), reimbursed prescription (“Rx-reimbursed”) products and natural extracts. It is a part of Meda AB now.
|
|
|
|
|
explore the most comprehensive database
900 000
bonds globally
Over 400
pricing sources
80 000
stocks
116 000
ETF & Funds
track your portfolio in the most efficient way
full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.
Register